助手标题
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
共[18]条 当前为第1条到18条
 

相关语句
重性抑郁症
    A Correlative Study between Neuropsychological Tests and Serum Cortisol Level of Major Depression
    重性抑郁症的神经心理与血清皮质醇水平的相关研究
    Clinical study of major depression comorbid with anxiety
    重性抑郁症共病焦虑障碍的临床研究
    Results The prevalence of depressive disorders and anxious disorders were 23.8% and 34.8% respectively, and prevalence rate of major depression, dysthymia and panic attack were 3.6%, 2.4% and1.2% respectively.
    结果亚临床抑郁性障碍和焦虑性障碍的患病率分别为23.7%和34.8%,重性抑郁症、心境恶劣、惊恐障碍和躯体形式障碍的患病率分别为3.6%、2.4%、1.2%和1.0%;
    Results The incidence of the depressive disorders and the anxious disorders were 26.8%,39.5% respectively,and the incidence of major depression,dysthymia,somatic disorders and panic attack were 4.3%,2.5%,2.5%and 1.0% respectively.
    结果 亚临床抑郁性障碍和焦虑性障碍的患病率分别 2 6.8%和 39.5% ,重性抑郁症、心境恶劣、躯体形式障碍和惊恐障碍的患病率分别为 4 .3%、2 .5%、2 .5%、1 .0 % ;
    Objective To investigate the differences of clinical character between neurotic depression(ND) and major depression(MD).
    目的 比较抑郁性神经症 (ND)和重性抑郁症 (MD)的临床特征的差异。
    Method 40 patients with major depression,36 with dysthymia according to DSM-Ⅳ,and 37 normal controls were tested by WAIS,Logical Memory and Visual Reproduction subsets of WMS,Stroop Test,Verbal Fluency,Trails Making,Tower of Hanoi,and Modified version of Wisconsin Card Sorting Test.
    方法 对符合DSM-Ⅳ的 40例重性抑郁症、36例心境恶劣障碍和 37例正常对照使用WAIS智力全套测验、WMS逻辑记忆与视觉再生测验、STROOP、词汇流畅性、延线测验A、B、汉诺塔、威斯康辛卡片分类测验改良版 (M -WCST)进行评测。
    Methods:15 patients with major depression co morbidity anxiety(study group) and 15 patients with major depression(control group) diagnosed by DSM-IV were involved in the study using polymerase chain reaction (PCR) and restriction fragment length polymorphism(RFLP) technique.
    方法:应用聚合酶链反应(PCR)和限制性片段长度多态性(RFLP)技术,检测15例重性抑郁症共病焦虑障碍患者(研究组)和15例单纯诊断为重性抑郁症患者(对照组)的COMT基因多态性。
    The Brain Structural and Functional Mechanism of Facial Emotion Recognition in Patients with a First Episode of Major Depression
    首发重性抑郁症患者面部表情认知的脑结构和功能机制
    A comparison between major depression and dysthymia on neuropsychological tests.
    重性抑郁症与心境恶劣障碍的神经心理学对比研究
    Coping Style, Social Support and Personality in Patients with Comorbid Major Depression and Anxiety
    重性抑郁症共病焦虑障碍的应对方式、社会支持和人格特征研究
    The polymorphism of catechol-O-methyltransferase gene between the patients with major depression and the patients with major depression co morbidity anxiety disorder
    重性抑郁症共病焦虑障碍与重性抑郁症的儿茶酚氧位甲基转移酶基因多态性研究
    Methods 42 patients who met the CCMD - 2 - R criteria of major depression were randomly divided into research (fluoxetine) and control (imipramine) groups for the treatment of 6 weeks. The efficacy were assessed by Hamilton Depression Rating Scale (HAMD) and Clinical Global Impression( CGI) ,and the side effects were assessed by Treatment E-mergent Symptoms Scale (TESS) .
    方法 对42例符合CCMD-2-R诊断标准的重性抑郁症住院患者,随机分组,分别用氟西汀和丙咪嗪治疗6周,用汉密尔顿抑郁量表(HAMD)和临床疗效总评量表(CGI)评定临床疗效,用副反应量表(TESS)评定副反应。
    Objestive:To explore the personality traits of patients with major depression and dysthymic disorder in remission and to determine the difference of dimension ,trait level ,model of personality and personality disorder between depressive and normal subjects.
    目的 :研究重性抑郁症 (MDD)和心境恶劣障碍 (DD)患者在人格维度、人格特质水平及人格模型及人格障碍倾向性方面的特征。
    Objective: To explore the coping style, social support and personality in patients with comorbid major depression and anxiety;
    目的:了解重性抑郁症共病焦虑障碍的应对方式、社会支持和人格特征。
    Methods: 77 patients with major depression were assessed by TCSQ, SSRS and EPQ, among whom 50 patients had no anxiety disorders and 27 comorbid with anxiety disorders.
    方法:采用社会支持评定量表(SSRS)、特质应对方式问卷(TCSQ)和艾森克人格问卷(EPQ),对共病焦虑障碍的重性抑郁症与非共病焦虑障碍的重性抑郁症患者进行评估。
    Conclusion: Patients with comorbid major depression and anxiety have maladaptive coping style and higher level of social support status, but difference in personality was not found in comorbid and no-comorbid.
    两组患者EPQ各维度评分之间均无显著性差异(P>0.05)。 结论:与非共病患者相比,共病焦虑障碍的重性抑郁症患者社会支持较高、应对方式更为消极,未发现共病者与非共病者在人格方面的差异。
    ObjectiveTo investigate the prevalence of anxiety disorder comorbidity in major depression,and study the impacts of comorbidity on symptoms, course and prognosis of major depression.
    目的调查重性抑郁症患者共病焦虑障碍的发生率,探讨共病对重性抑郁症症状及预后的影响。
    Objective:To investigate the difference of the polymorphism of catechol-O-methyltransferase gene between the patients with major depression and the patients with major depression co morbidity anxiety disorder.
    目的:探讨重性抑郁症共病焦虑障碍患者与重性抑郁症患者儿茶酚氧位甲基转移酶(COMT)基因多态性的差异。
 

首页上一页1下一页尾页 

 
CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社